Literature DB >> 30919146

Evolving patterns of reactive arthritis.

Kaitlyn M Hayes1, Reid J P Hayes2, Matthew A Turk3, Janet E Pope4,5.   

Abstract

OBJECTIVE: To characterize rheumatologists' perspectives on evolving trends of reactive arthritis (ReA).
METHODS: After ethics approval, 548 members of the Canadian Rheumatology Association were surveyed with 37 questions covering their demographic information, subspecialty, level of experience, practice setting and opinions on prevalence, treatment, and causes of ReA. Results were analyzed with descriptive statistics.
RESULTS: Ninety-seven responded to the survey (18% response rate); 66 fully completed it. Nearly half of respondents believed that the incidence of ReA is declining and causes of ReA may be changing. Physicians reported that most of the ReA cases in their practices were caused by an unknown organism, sexually transmitted, or gastrointestinal infection. Full triad ReA increased the chance of recurrence according to their impressions. Common investigations in ReA included inflammatory markers, HLA-B27, chlamydia and gonorrhea testing, stool cultures, synovial fluid analyses, SI joint imaging. ReA treatment included NSAIDs, intra-articular corticosteroid injections, and DMARDs. Two-thirds said they used TNF alpha inhibitors in chronic ReA occasionally or more frequently.
CONCLUSION: ReA may be decreasing in frequency and severity in Canada. Changes could be due to less food borne illness, cleaner water, or more rapid treatment of sexually transmitted infections. The cause is often unknown in clinical practice.Key Points• Reactive arthritis (ReA) is likely decreasing in prevalence and severity.• Patients with classic trial of arthritis, urethritis, and conjunctivitis are more likely to have recurrent and/or chronic ReA.• The causal organisms are often not detected and seem to be changing over time.

Entities:  

Keywords:  Evolving trends; Reactive arthritis; Reiter’s syndrome; Survey; Treatment

Mesh:

Substances:

Year:  2019        PMID: 30919146     DOI: 10.1007/s10067-019-04522-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  5 in total

Review 1.  Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens.

Authors:  Henning Zeidler; Alan P Hudson
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

Review 2.  Reactive Arthritis: Update.

Authors:  Ibtissam Bentaleb; Kawther Ben Abdelghani; Samira Rostom; Bouchra Amine; Ahmed Laatar; Rachid Bahiri
Journal:  Curr Clin Microbiol Rep       Date:  2020-09-26

Review 3.  [Postinfectious reactive arthritis after chlamydia infection in competitive sports : Clinical management and current literature review].

Authors:  Sebastian Klingebiel; Horst Rieger; Georg Gosheger; Jan Christoph Theil; Carolin Rickert; Kristian Nikolaus Schneider
Journal:  Orthopade       Date:  2021-03       Impact factor: 1.087

4.  Approaching Reactive Arthritis Associated With Poor Prognostic Factors: A Case Report and Literature Review.

Authors:  Swetha Ann Alexander; Eunjung Kim; Ranadeep Mandhadi
Journal:  Cureus       Date:  2021-02-25

Review 5.  Reactive arthritis before and after the onset of the COVID-19 pandemic.

Authors:  Dana Bekaryssova; Marlen Yessirkepov; Olena Zimba; Armen Yuri Gasparyan; Sakir Ahmed
Journal:  Clin Rheumatol       Date:  2022-03-05       Impact factor: 3.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.